The Sequencing laboratory operates under Good Laboratory Practice/ Good Clinical Laboratory Practice (GLP/GCLP) standards and provides services to clients in the academic, industrial, and pharmaceutical communities. All operations are conducted following Standard Operating Procedure (SOP) and all experiments workflows are documented in a Laboratory Information Management System (LIMS). The Pharmacogenomics Centre is equipped with the Illumina NovaSeq 6000 and MiSeq technologies giving a broad range of experimental design possibilities from whole genome sequencing to small targeting sequencing. As part of its core expertise, the Pharmacogenomics Centre posses a Bioinformatics team allowing a complete service from the data analysis, interpretation to data reporting.
The Pharmacogenomics Centre offers sequencing project evaluation and planning.
Sequencing Core Expertise
- Targeting Sequencing
- Whole Genome Sequencing
- Whole Exome Sequencing
- V2 chemistry: up to 8.5 GB of data or 30 Million billion PE reads per Flow Cell
- V3 chemistry: up to 15 GB of data or 50 Million billion PE reads per Flow Cell
- NovaSeq 6000
- V1.5 chemistry: up to 3000 Gb of data or 20 Million billion PE reads per Flow Cell
Ian Mongrain, M.Sc.
Directeur des opérations/Director of operations
Beaulieu-Saucier Pharmacogenomics Centre
Montreal Heart Institute, office S-2050
5000, Belanger East, Montreal
Qc, Canada, H1T1C8
Office: 514-670-7670, 7716
CA/USA: 1-855-670-7670, 7716